Anzeige
Mehr »
Login
Samstag, 19.09.2020 Börsentäglich über 12.000 News von 646 internationalen Medien
Warum Anleger jetzt noch schnell 100% verdienen können! Absolute Depot-Booster-Aktie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Xconomy

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19.08.J&J Boosts Autoimmune Disease Drug Pipeline With $6.5B Momenta Buyout
19.08.Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold
18.08.Unity Biotech Arthritis Drug Flunks Phase 2, Spelling Program's End
18.08.Genentech Gets FDA OK for Injectable Rare Neuroimmune Disease Drug
18.08.Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor
17.08.Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy
17.08.Sanofi Reaches $3.68B Deal to Buy Principia and Partnered MS Drug
15.08.Advisory Body Backs MesoBlast Therapy for Transplant Complication
15.08.CureVac's IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears
14.08.Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More
13.08.With FDA Nod, NS Pharma Duchenne Drug Becomes Sarepta Competitor
12.08.Perceptive Advisors' LianBio Inks Deals With BridgeBio, MyoKardia
12.08.F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections
12.08.Pfizer's Bourla: There's Coronavirus Vaccine Pressure, But It's Not Political
11.08.Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup
11.08.Bayer Boosts Women's Health Drug Pipeline, Paying $425M for KaNDy
11.08.Roche Gut Disease Drug Produces Mixed Results in Late-Stage Trials
10.08.Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3
08.08.FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
07.08.AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
07.08.Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More
07.08.Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare
07.08.GlaxoSmithKline Multiple Myeloma Drug Earns FDA's First Anti-BCMA Nod
06.08.G1 Vets Launch Arc Therapeutics to Take on New Cancer Target
06.08.Biogen to Pay Denali $1B to Partner on Parkinson's Drug & Other Neuro Meds